Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Tolerance on Dose-dependent Effects of Acute THC on Oculomotor and Cognitive Performance
NCT06351540Phase 1Not yet recruiting
- Sponsor
- Johns Hopkins University
- Start
- Dec 2026
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dronabinol (3 arms), sponsored by Johns Hopkins University. Primary endpoints: Commission Errors at 4 hours, Omission Errors at 4 hours and 3 more. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NCT06351540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06351540.